- Comparative effects of systemic administration of levofloxacin and cephalexin on fracture healing in rats
-
Golestani S, Golestaneh A, Gohari AA
- KMID: 2529922
- J Korean Assoc Oral Maxillofac Surg.
- 2022 Apr;48(2):94-100.
- doi: 10.5125/jkaoms.2022.48.2.94
Objectives: This study aimed to compare the effects of systemic administration of levofloxacin or cephalexin on fracture healing in rats. Materials and Methods: In this animal study, tibial fractures not requiring... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen
-
Kim SI, Jung SH, Yhim HY, Jo JC, Song GY, Kim M, Ahn SY, Ahn JS, Yang DH, Kim HJ, Lee JJ
- KMID: 2527497
- Blood Res.
- 2022 Mar;57(1):51-58.
- doi: 10.5045/br.2021.2021176
Background Although survival outcomes of multiple myeloma (MM) have improved with the development of new and effective agents, infection remains the major cause of morbidity and mortality. Here, we evaluated the... -
- CITED
-
- Close
- SHARE
-
- Close
- Severe Thrombocytopenia in a Patient with COVID-19
-
Nham E, Ko JH, Jeong BH, Huh K, Cho SY, Kang CI, Chung DR, Peck KR
- KMID: 2507537
- Infect Chemother.
- 2020 Sep;52(3):410-414.
- doi: 10.3947/ic.2020.52.3.410
Coronavirus disease 2019 (COVID-19) outbreak is spreading rapidly all over the world, being a major threat to public health. Since clinical feature of COVID-19 has not been fully evaluated yet,... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacokinetic profiles of levofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits (Oryctolagus cuniculus)
-
Sitovs A, Voiko L, Kustovs D, Kovalcuka L, Bandere D, Purvina S, Giorgi M
- KMID: 2506177
- J Vet Sci.
- 2020 Mar;21(2):e32.
- doi: 10.4142/jvs.2020.21.e32
Levofloxacin pharmacokinetic profiles were evaluated in 6 healthy female rabbits after intravenous (I/V), intramuscular (I/M), or subcutaneous (S/C) administration routes at a single dose of 5 mg/kg in a 3... -
- CITED
-
- Close
- SHARE
-
- Close
- Levofloxacin-induced Fixed Drug Eruption: A Case Report
-
Han SS, Oh EH, Kwon HI, Ko JY, Ro YS, Kim JE
- KMID: 2391167
- Korean J Dermatol.
- 2017 Aug;55(7):445-448.
Fixed drug eruptions (FDEs) are characterized by the presence of site-specific recurrence of a solitary or multiple, well-circumscribed, erythematous macules or patches that recur with each exposure to a particular... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
-
Lim JH, Kim SG, Song JH, Hwang JJ, Lee DH, Han JP, Hong SJ, Kim JH, Jeon SW, Kim GH, Shim KN, Shin WG, Kim TH, Kim SM, Chung IK, Kim HS, Kim HU, Lee J, Kim JG
- KMID: 2412188
- Gut Liver.
- 2017 Mar;11(2):226-231.
- doi: 10.5009/gnl16099
BACKGROUND/AIMS: The resistance rate of Helicobacter pylori is gradually increasing. We aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic ulcer disease. METHODS: Between 2002 and 2014,... -
- CITED
-
- Close
- SHARE
-
- Close
- Eradication Rate by Duration of Third-line Rescue Therapy with Levofloxacin after Helicobacter pylori Treatment Failure in Clinical Practice
-
Noh HM, Hong SJ, Han JP, Park KW, Lee YN, Lee TH, Ko BM, Lee JS, Lee MS
- KMID: 2383503
- Korean J Gastroenterol.
- 2016 Nov;68(5):260-264.
- doi: 10.4166/kjg.2016.68.5.260
BACKGROUND/AIMS: This study evaluated the eradication rate of levofloxacin-containing rescue therapy by treatment duration in patients in whom previous first- and second-line treatment failed. METHODS: Fifty-five patients with persistent Helicobacter pylori... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacokinetic comparison of two levofloxacin 100-mg tablet formulations and determination of time point appropriately reflecting its area under the curve
-
Park KR, Jang K, Lee S, Yu KS, Kim BH, Yim SV
- KMID: 2290474
- Transl Clin Pharmacol.
- 2016 Jun;24(2):84-89.
- doi: 10.12793/tcp.2016.24.2.84
Levofloxacin is a broad-spectrum antibiotic with activity against gram-positive and -negative bacteria. This study compared the pharmacokinetics (PK) and evaluated the bioequivalence of two levofloxacin 100-mg tablet formulations. An open,... -
- CITED
-
- Close
- SHARE
-
- Close
- A bioequivalence study of two levofloxacin tablets in healthy male subjects
-
Chung I, Yoon S, Yi S, Kim BH, Yim SV, Jang IJ, Lee H
- KMID: 2050943
- Transl Clin Pharmacol.
- 2014 Dec;22(2):102-105.
- doi: 10.12793/tcp.2014.22.2.102
Levofloxacin is a bactericidal broad spectrum antibiotic against Gram-positive and Gram-negative pathogens. A randomized, two-treatment, two-period, two-way crossover study was conducted to evaluate the bioequivalence of Lectacin 250 mg tablet,... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Factors Associated with Acquisition of Resistance to Levofloxacin in Stenotrophomonas maltophilia
-
Baek JH, Kim CO, Jeong SJ, Ku NS, Han SH, Choi JY, Yong D, Song YG, Lee K, Kim JM
- KMID: 2130824
- Yonsei Med J.
- 2014 Jul;55(4):987-993.
- doi: 10.3349/ymj.2014.55.4.987
PURPOSE: Fluoroquinolones, rapidly gaining prominence in treatment of Stenotrophomonas maltophilia (SMP), are noted for their potency and tolerability. However, SMP may rapidly acquire resistance to fluoroquinolones. We evaluated associations of... -
- CITED
-
- Close
- SHARE
-
- Close
- Epithelial Wound Healing after Cataract Surgery Comparing Two Different Topical Fluoroquinolones
-
Han KE, Chung WS, Kim TI, Kim S, Kim T, Kim EK
- KMID: 1779906
- Yonsei Med J.
- 2014 Jan;55(1):197-202.
- doi: 10.3349/ymj.2014.55.1.197
PURPOSE: To compare the epithelial wound healing response of two preservative-free fluoroquinolones, moxifloxacin and levofloxacin, in patients who underwent cataract surgery. MATERIALS AND METHODS: In this prospective, evaluator-masked, randomized clinical trial,... -
- CITED
-
- Close
- SHARE
-
- Close
- Efflux-mediated resistance identified among norfloxacin resistant clinical strains of group B Streptococcus from South Korea
-
Dang TN, Srinivasan U, Britt Z, Marrs CF, Zhang L, Ki M, Foxman B
- KMID: 2380566
- Epidemiol Health.
- 2014;36:e2014022.
- doi: 10.4178/epih/e2014022
OBJECTIVES: Group B Streptococcus (GBS), a common bowel commensal, is a major cause of neonatal sepsis and an emerging cause of infection in immune-compromised adult populations. Fluoroquinolones are used to... -
- CITED
-
- Close
- SHARE
-
- Close
- Clostridium difficile Colitis after Topical Ophthalmic Use of Levofloxacin
-
Lee JW, Woo SY, Park SJ, Hong SH, Lee SY, Woo SM
- KMID: 1726726
- Ewha Med J.
- 2013 Dec;36(Suppl):S5-S8.
- doi: 10.12771/emj.2013.36.S.S5
Clostridium difficile colitis (CDC) has been associated with virtually all available antibiotics. It is well known that administration of drugs by the ocular route can result in systemic absorption with... -
- CITED
-
- Close
- SHARE
-
- Close
- Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment of Helicobacter pylori Infection in Korea
-
Moon JY, Kim GH, You HS, Lee BE, Ryu DY, Cheong JH, Jung JI, Jeong JH, Song CS, Song GA
- KMID: 1806637
- Gut Liver.
- 2013 Jul;7(4):406-410.
BACKGROUND/AIMS: Several rescue therapies have been recommended to eradicate Helicobacter pylori infection in patients with a failure of first-line eradication therapy, but they still fail in more than 20% of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Levofloxacin-Induced Anaphylaxis With Elevated Serum Tryptase Levels
-
Lee JH, Lee WY, Yong SJ, Shin KC, Lee MK, Kim CW, Kim SH
- KMID: 2260348
- Allergy Asthma Immunol Res.
- 2013 Mar;5(2):113-115.
- doi: 10.4168/aair.2013.5.2.113
Levofloxacin, a fluoroquinolone and L-isomer of the racemate ofloxacin, has been approved for the treatment of acute and chronic bacterial infections. Gastrointestinal complaints are the most frequently reported adverse drug... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Rifabutin- and Levofloxacin-based Third-line Rescue Therapies for Helicobacter pylori
-
Jeong MH, Chung JW, Lee SJ, Ha M, Jeong SH, Na S, Na BS, Park SK, Kim YJ, Kwon KA, Ko KI, Jo Y, Hahm KB, Jung HY
- KMID: 1792844
- Korean J Gastroenterol.
- 2012 Jun;59(6):401-406.
- doi: 10.4166/kjg.2012.59.6.401
BACKGROUND/AIMS: There is increasing need for third-line therapy of Helicobacter pylori due to increasing level of antibiotics resistance. The aim of this study was to compare rifabutin and levofloxacin rescue... -
- CITED
-
- Close
- SHARE
-
- Close
- Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from a Korean Tertiary Care Hospital
-
Chung HS, Hong SG, Lee Y, Kim M, Yong D, Jeong SH, Lee K, Chong Y
- KMID: 1120215
- Yonsei Med J.
- 2012 Mar;53(2):439-441.
- doi: 10.3349/ymj.2012.53.2.439
We determined the antimicrobial susceptibility of 90 clinical isolates of Stenotrophomonas maltophilia collected in 2009 at a tertiary care hospital in Korea. Trimethoprim-sulfamethoxazole, minocycline, and levofloxacin were active against most... -
- CITED
-
- Close
- SHARE
-
- Close
- Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment Outcomes
-
Lee J, Lee CH, Kim DK, Yoon HI, Kim JY, Lee SM, Yang SC, Lee JH, Yoo CG, Lee CT, Chung HS, Kim YW, Han SK, Yim JJ
- KMID: 1776587
- Korean J Intern Med.
- 2011 Jun;26(2):153-159.
- doi: 10.3904/kjim.2011.26.2.153
BACKGROUND/AIMS: To compare the effect of levofloxacin and moxifloxacin on treatment outcomes among patients with multidrug-resistant tuberculosis (MDR-TB). METHODS: A retrospective analysis of 171 patients with MDR-TB receiving either levofloxacin or... -
- CITED
-
- Close
- SHARE
-
- Close
- Reduced Levofloxacin Susceptibility in Clinical Respiratory Isolates of Haemophilus Influenzae Is Not yet Associated with Mutations in the DNA Gyrase and Topoisomerase II Genes in Korea
-
Kim IS, Lee NY, Kim S, Ki CS, Kim SH
- KMID: 1106455
- Yonsei Med J.
- 2011 Jan;52(1):188-191.
- doi: 10.3349/ymj.2011.52.1.188
Among 155 clinical respiratory isolates of Haemophilus influenzae in Korea, 6 (3.9%) isolates had reduced levofloxacin susceptibility (MICs > or = 0.5 microg/mL). These six isolates had no significant quinolone... -
- CITED
-
- Close
- SHARE
-
- Close
- Levofloxacin and Torsades de Pointes
-
Kwon SA, Kim CH, Song WJ, Koo JK, Lee SJ, Park JY, Hyun IG, Ko JH, Kim HS
- KMID: 2319459
- Tuberc Respir Dis.
- 2010 Dec;69(6):474-479.
Torsades de pointes associated with a prolonged QT interval is a life-threatening arrhythmia, which may be induced by any of the following: drugs, electrolyte imbalances, severe bradycardia and intracranial hemorrhage.... -
- CITED
-
- Close
- SHARE
-
- Close
